These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31773164)

  • 1. In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.
    Miura A; Kano R; Ito T; Suzuki K; Kamata H
    Med Mycol; 2020 Aug; 58(6):845-847. PubMed ID: 31773164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
    Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
    Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human protothecosis.
    Lass-Flörl C; Mayr A
    Clin Microbiol Rev; 2007 Apr; 20(2):230-42. PubMed ID: 17428884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
    Blaschke-Hellmessen R
    Mycoses; 1996; 39 Suppl 2():39-43. PubMed ID: 9198743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre Etest evaluation of in vitro activity of conventional antifungal drugs against European bovine mastitis Prototheca spp. isolates.
    Jagielski T; Buzzini P; Lassa H; Malinowski E; Branda E; Turchetti B; Polleichtner A; Roesler U; Lagneau PE; Marques S; Silva E; Thompson G; Stachowiak R; Bielecki J
    J Antimicrob Chemother; 2012 Aug; 67(8):1945-7. PubMed ID: 22523316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Characteristics of Prototheca Species Occurring in Humans and Animals.
    Kano R; Kazuo Satoh ; Yaguchi T; Masuda M; Makimura K; de Hoog GS
    Med Mycol J; 2022; 63(1):17-20. PubMed ID: 35228481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Diekema DJ; Messer SA; Hollis RJ; Jones RN; Pfaller MA
    J Clin Microbiol; 2003 Aug; 41(8):3623-6. PubMed ID: 12904365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
    Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protothecosis.
    Mayorga J; Barba-Gómez JF; Verduzco-Martínez AP; Muñoz-Estrada VF; Welsh O
    Clin Dermatol; 2012; 30(4):432-6. PubMed ID: 22682193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.
    Linares MJ; Solís F; Casal M
    J Clin Microbiol; 2005 May; 43(5):2520-2. PubMed ID: 15872301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
    Kano R; Hiruma J; Yokota M; Noguchi H; Hase M; Kamata H; Harada K; Hiruma M
    Jpn J Infect Dis; 2020 May; 73(3):250-252. PubMed ID: 31875604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The In Vitro Efficacy of Essential Oils and Antifungal Drugs Against Prototheca zopfii.
    Grzesiak B; Głowacka A; Krukowski H; Lisowski A; Lassa H; Sienkiewicz M
    Mycopathologia; 2016 Aug; 181(7-8):609-15. PubMed ID: 26940809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Madurella mycetomatis is highly susceptible to ravuconazole.
    Ahmed SA; Kloezen W; Duncanson F; Zijlstra EE; de Hoog GS; Fahal AH; van de Sande WW
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2942. PubMed ID: 24945848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: In vitro antimicrobial susceptibility of Prototheca wickerhamii and Prototheca zopfii isolated from bovine mastitis.
    Marques S; Silva E; Carvalheira J; Thompson G
    J Dairy Sci; 2006 Nov; 89(11):4202-4. PubMed ID: 17033006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
    Yamazumi T; Pfaller MA; Messer SA; Houston A; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2883-6. PubMed ID: 10991880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs.
    Watanabe T; Ishikawa T; Sato H; Hirose N; Nonaka L; Matsumura K; Masubuchi A; Nishimura K; Masuda M
    Med Mycol; 2021 Sep; 59(9):855-863. PubMed ID: 33838030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole cross-resistance in Aspergillus fumigatus.
    Mosquera J; Denning DW
    Antimicrob Agents Chemother; 2002 Feb; 46(2):556-7. PubMed ID: 11796377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.